Bob Laverty Email & Phone Number

Provides strategic consulting counsel to several preclinical biotech and established pharmaceutical clients with a focus on creating messaging and brand awareness that differentiates from the competition

Providing strategic communications counsel to executive leadership at pre-IPO biotech companies and nonprofit patient advocacy organizations.

Parsippany, Nj

Responsible for corporate communications as well as global brand communications in the acute cardiovascular, infectious diseases and surgery and peri-operative care areas. Worked closely with Investor Relations to create communications to help build greater shareholder value.

Firm provided strategic communications counsel to clients in the global pharmaceutical and biotech industry. Specialized in working with clients to help develop message and brand strategy, corporate reputation planning and positioning, organizational effectiveness and strategy, and crisis planning and management. Solid experience in preparing senior level executives for interaction with both internal and external stakeholders.

Head of corporate communications and investor relations for the U.S.-based subsidiary of Eisai Corporation, serving as the principal communications liaison with colleagues in Tokyo and Europe. Transformed the Corporate Communications organization by attracting several key hires and streamlining the policies and processes which guided the internal and external communications activities. Elevated the role and expectations of Corporate Communications among executive management to establish the function as a core capability to support the future growth of Eisai in the U.S.

Served as vice president of external communications for the U.S. company, coordinating all global pharma press releases, including development, media strategy, approval and distribution. Implemented several news and business monitoring processes to create an effective media management function within Novartis Pharma. Also developed strong communications flow with Corporate in Basel, as well as Global Brand Teams, to more effectively manage media communications for all Global Pharma announcements across top ten markets in the world. Assumed head of communications role for company's malaria initiative, developing and implementing all global communications supporting the company’s not-for-profit malaria initiative in the developing world.

Assumed roles of increasing responsibility in the product communications, corporate and public affairs function within BMS. Served as senior communications counsel on US Pharma executive committee. Worked closely with all levels of senior management on critical business issues.

Greater New York City Area

Worked as an account executive with several major multinational pharma companies on product launches and critical corporate issues.